Skip to main content
< Back to news
ICREA researchers Eduard Batlle and Angel R. Nebreda (Photos: IRB Barcelona).
 10.09.2018

IRB Barcelona has been awarded two ERC Proof of Concept to tackle colon cancer and cardiotoxicity

Eduard Batlle and Angel R. Nebreda, ICREA researchers at the Institute for Research in Biomedicine (IRB Barcelona), have been awarded an ERC Proof of Concept grant. Over the next 18 months and supported by 150,000 euros of funding each, they will devote their efforts to developing tools with potential therapeutic applications in the field of oncology. This is the second time that these scientists have received an ERC PoC grant.

 

The team from the Colorectal Cancer Lab, headed by Eduard Batlle, will build a biobank of mouse tumour organoids with the aim to contribute to the treatment of patients with advanced colon cancer.

The project led by Angel R. Nebreda, head of the Signalling and Cell Cycle Lab, aims to develop therapeutic tools with the capacity to reduce cardiotoxicity and damage to heart muscle.

The Proof of Concept grants awarded by the European Research Council (ERC) seek to support those projects previously funded by this organisation and place special emphasis on those ideas that may improve social wellbeing.

► More information: IRB Barcelona website [+]